Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
58.61
Dollar change
+1.26
Percentage change
2.20
%
IndexRUT P/E- EPS (ttm)-1.66 Insider Own1.16% Shs Outstand49.69M Perf Week0.50%
Market Cap2.91B Forward P/E12.61 EPS next Y4.65 Insider Trans-5.78% Shs Float49.04M Perf Month-1.51%
Income-81.77M PEG- EPS next Q1.04 Inst Own104.22% Short Float / Ratio3.26% / 7.26 Perf Quarter0.41%
Sales1.13B P/S2.58 EPS this Y2.49% Inst Trans-2.91% Short Interest1.60M Perf Half Y0.19%
Book/sh30.96 P/B1.89 EPS next Y7.69% ROA-2.33% Target Price72.20 Perf Year-4.64%
Cash/sh1.21 P/C48.41 EPS next 5Y8.00% ROE-5.18% 52W Range52.90 - 68.54 Perf YTD-6.37%
Dividend- P/FCF13.48 EPS past 5Y- ROI-2.91% 52W High-14.48% Beta0.53
Dividend %- Quick Ratio1.75 Sales past 5Y1.87% Gross Margin52.83% 52W Low10.79% ATR1.23
Employees560 Current Ratio2.99 Sales Q/Q-1.02% Oper. Margin31.04% RSI (14)50.98 Volatility1.80% 2.30%
OptionableYes Debt/Eq0.83 EPS Q/Q5.35% Profit Margin-7.26% Rel Volume1.11 Prev Close57.35
ShortableYes LT Debt/Eq0.83 EarningsNov 02 BMO Payout- Avg Volume220.13K Price58.61
Recom1.43 SMA200.24% SMA50-0.27% SMA200-2.26% Volume243,418 Change2.20%
Date Action Analyst Rating Change Price Target Change
Nov-17-22Initiated Canaccord Genuity Buy $71
May-10-22Upgrade Jefferies Hold → Buy $65 → $70
May-09-22Upgrade Oppenheimer Perform → Outperform $63
Aug-07-20Downgrade DA Davidson Buy → Neutral
Jun-29-20Upgrade Sidoti Neutral → Buy
Apr-14-20Downgrade Jefferies Buy → Hold
Apr-07-20Resumed Sidoti Neutral $46
Mar-26-20Upgrade Jefferies Hold → Buy $43
Mar-24-20Initiated Oppenheimer Perform
Mar-19-20Upgrade DA Davidson Neutral → Buy
Nov-29-23 07:08AM
Nov-24-23 08:30AM
Nov-08-23 09:40AM
Nov-05-23 01:42PM
Nov-02-23 12:31PM
06:00AM Loading…
06:00AM
Oct-05-23 04:30PM
Sep-29-23 09:45AM
Sep-22-23 09:40AM
Sep-19-23 09:00AM
Sep-06-23 09:35AM
Sep-05-23 05:00PM
Aug-16-23 12:45PM
Aug-03-23 09:30AM
07:25AM
06:21AM Loading…
06:21AM
06:00AM
Jul-19-23 11:40AM
Jul-11-23 08:00AM
Jul-06-23 04:30PM
Jun-21-23 08:00PM
Jun-16-23 11:40AM
Jun-05-23 09:00AM
Jun-01-23 10:54AM
May-31-23 11:40AM
09:00AM
May-30-23 06:50AM
May-23-23 02:00PM
May-15-23 11:40AM
May-05-23 08:49AM
07:35AM Loading…
May-04-23 07:35AM
06:32AM
06:00AM
Apr-26-23 08:00PM
Apr-18-23 08:00AM
Feb-25-23 08:14AM
Feb-02-23 07:15AM
06:00AM
Jan-09-23 08:00AM
Jan-05-23 04:30PM
Jan-02-23 09:06AM
Dec-12-22 12:05PM
Nov-26-22 07:05AM
Nov-09-22 06:37AM
Nov-03-22 07:25AM
06:00AM
Oct-27-22 10:03AM
Oct-04-22 04:30PM
Sep-28-22 09:40AM
Sep-20-22 02:45PM
Sep-18-22 08:26AM
Sep-07-22 05:03PM
Aug-29-22 09:35AM
Aug-23-22 12:00PM
Aug-04-22 07:25AM
06:00AM
Jul-26-22 08:33AM
Jul-11-22 04:30PM
Jun-09-22 08:44AM
May-05-22 08:25PM
04:30PM
Apr-14-22 08:53AM
Apr-11-22 07:12AM
Apr-01-22 09:52PM
Mar-19-22 09:46AM
Mar-17-22 03:08PM
Feb-16-22 11:38AM
Feb-04-22 02:38PM
12:00PM
09:38AM
Feb-03-22 07:15AM
06:00AM
Jan-27-22 03:01PM
Jan-13-22 04:53PM
Jan-10-22 04:30PM
Dec-31-21 09:17AM
Nov-04-21 07:55AM
06:00AM
Nov-01-21 03:15PM
Oct-28-21 03:05PM
Oct-06-21 04:30PM
Sep-27-21 11:40AM
Sep-21-21 07:35AM
Sep-10-21 11:40AM
Aug-31-21 12:20PM
Aug-25-21 11:40AM
Aug-09-21 11:40AM
Aug-05-21 07:45AM
06:00AM
Jul-29-21 03:05PM
Jul-23-21 06:14AM
Jul-20-21 04:15PM
Jul-01-21 04:01PM
May-27-21 08:30AM
May-24-21 06:13AM
May-07-21 05:00PM
May-06-21 09:15AM
06:30AM
06:00AM
Apr-29-21 05:00PM
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fritz Mary BethSVP Quality & RegulatorySep 14Option Exercise30.562,54077,62218,474Sep 15 04:03 PM
Fritz Mary BethSVP Quality & RegulatorySep 14Sale58.922,540149,65715,934Sep 15 04:03 PM
Lombardi Ronald M.Chief Executive OfficerAug 08Option Exercise33.5032,8001,098,800303,357Aug 09 04:01 PM
Lombardi Ronald M.Chief Executive OfficerAug 08Sale65.5732,8002,150,536270,557Aug 09 04:01 PM
Sacco ChristineChief Financial OfficerMay 24Option Exercise50.0537,0291,853,19270,980May 26 04:04 PM
Sacco ChristineChief Financial OfficerMay 24Sale60.0755,2943,321,51126,969May 26 04:04 PM
Mekhail AdelEVP, Marketing & SalesMay 19Option Exercise30.1917,194519,08728,681May 22 04:05 PM
Mekhail AdelEVP, Marketing & SalesMay 19Sale62.3617,1941,072,28618,681May 22 04:05 PM
Fritz Mary BethSVP Quality & RegulatoryMay 15Option Exercise29.468,154240,21724,088May 16 04:07 PM
Fritz Mary BethSVP Quality & RegulatoryMay 15Sale58.808,154479,45515,934May 16 04:07 PM
P'Pool WilliamSVP, GC & Corp SecretaryDec 06Option Exercise30.5614,780451,67735,313Dec 07 04:02 PM
P'Pool WilliamSVP, GC & Corp SecretaryDec 06Sale60.7614,780898,03320,533Dec 07 04:02 PM